無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

筋骨格系疾患治療の世界市場の分析と予測:疾患別 (関節炎、骨関節炎、骨粗鬆症、脊椎炎など)・画像モダリティ別 (MRI、CT、超音波など)・地域別

Musculoskeletal Diseases Treatment Market to 2025 - Global Analysis and Forecasts By Type (Arthritis, Osteoarthritis, Osteoporosis, Spondylitis, and Others); Imaging Modality (MRI, CT, Ultrasound, and Other Modalities) and Geography

発行 The Insight Partners 商品コード 749591
出版日 ページ情報 英文 148 Pages
即納可能
価格
本日の銀行送金レート: 1USD=111.44円で換算しております。
Back to Top
筋骨格系疾患治療の世界市場の分析と予測:疾患別 (関節炎、骨関節炎、骨粗鬆症、脊椎炎など)・画像モダリティ別 (MRI、CT、超音波など)・地域別 Musculoskeletal Diseases Treatment Market to 2025 - Global Analysis and Forecasts By Type (Arthritis, Osteoarthritis, Osteoporosis, Spondylitis, and Others); Imaging Modality (MRI, CT, Ultrasound, and Other Modalities) and Geography
出版日: 2018年09月26日 ページ情報: 英文 148 Pages
概要

当レポートでは、世界の肝臓病治療向け医療機器の市場について分析し、市場の基本構造や背景事情、主な促進・抑制要因、全体的な市場規模の動向見通し、疾患の種類別・画像モダリティ別・地域別 (主要国) の詳細動向、昨今の市場競争動向、主要企業のプロファイルなどを調査しております。

第1章 イントロダクション

第2章 分析概略

第3章 市場環境

  • 概要
  • 市場区分

第4章 世界の筋骨格系疾患治療市場:主な動向

  • 主な市場促進要因
  • 主な市場抑制要因
  • 主な市場機会
  • 将来の市場動向
  • 影響度の分析

第5章 筋骨格系疾患治療市場:世界市場の分析

  • 市場概要
  • 世界市場の予測と分析
  • 主要企業の業績
  • 専門家の見解

第6章 筋骨格系疾患治療市場の分析:種類別

  • 概要
  • 市場の予測と分析:種類別
  • 関節炎
    • 市場概要
    • 市場収益額とその予測 (金額ベース、今後8年間分)
  • 骨関節炎
  • 骨粗鬆症
  • 脊椎炎
  • その他

第7章 筋骨格系疾患治療市場の分析:画像モダリティ別

  • MRI (核磁気共鳴画像)
  • CT (コンピューター断層撮影)
  • 超音波

第8章 北米の筋骨格系疾患治療の市場

  • 市場概要
  • 市場収益額とその予測 (金額ベース、今後8年間分)
  • 市場収益額とその予測:種類別 (金額ベース、今後8年間分)
  • 市場収益額とその予測:画像モダリティ別 (金額ベース、今後8年間分)
  • 市場収益額とその予測:国別 (金額ベース、今後8年間分)
  • 米国市場
  • カナダ市場
  • メキシコ市場

第9章 欧州の筋骨格系疾患治療の市場

  • 英国市場
  • ドイツ市場
  • フランス市場

第10章 アジア太平洋地域筋の骨格系疾患治療の市場

  • 日本市場
  • 中国市場
  • インド市場

第11章 中東・アフリカの筋骨格系疾患治療の市場

  • 南アフリカ市場
  • サウジアラビア市場
  • アラブ首長国連邦 (UAE) 市場

第12章 中南米の筋骨格系疾患治療の市場

  • ブラジル市場

第13章 産業情勢

  • 有機的成長戦略
    • 新製品の発売
    • マーケティング/プロモーション活動
  • 無機的成長戦略
    • 事業提携・協力、合弁事業
    • 企業合併・買収 (M&A)

第14章 筋骨格系疾患治療市場:主要企業のプロファイル

  • キヤノンメディカルシステムズ
    • 主要データ
    • 事業概略
    • 主な財務指標
    • 製品ポートフォリオ
    • SWOT分析
    • 近年の主な動向
  • SIEMENS AG
  • ESAOTE S.P.A
  • 日立製作所
  • KONINKLIJKE PHILIPS N.V.
  • GENERAL ELECTRIC
  • 島津製作所
  • 富士フイルムホールディングス
  • ACCURAY INCORPORATED
  • 東芝

第15章 付録

目次
Product Code: TIPMD00002090

The global musculoskeletal diseases treatment market is expected to reach US$ 5,730.8 Mn in 2025 from US$ 3,837.9 in 2017. The musculoskeletal diseases treatment market is estimated to grow with a CAGR of 5.3% from 2018-2025.

The elderly population is defined as group of people aged 65 and over. Population ageing is poised to become one of the most significant social transformations of the twenty-first century. The number of geriatric population has been increasing rapidly across the globe. According to the data published by the United Nations, in 2017, there were an estimated 962 million people aged 60 or over in the world, which comprised of 13 per cent of the global population. The geriatric population is estimated to grow at a rate of 3% every year. However, the cost of the diagnostic systems are the major concern in the musculoskeletal diseases treatment market. The cost of the ultrasound used for the musculoskeletal diseases treatment is US$1,000 to US$ 5,000 per piece. The prices can vary according to the additional components added in the equipment. Additionally, the systems can be divided into low-field and high-field MRIs. A good quality MRI machines usually are on the very expensive side ranging between US$ 1.2 Million to US$ 5 Million. Advances in imaging technology and the rising interventional procedures in musculoskeletal imaging have continued to stimulate research since last years. Mobile MRI is the combination of scanner technology to provide a complete MRI solution in a mobile environment. For instance, in June 2018, Tata Trusts' Foundation for Innovation and Social Entrepreneurship (FISE) launched the portable magnetic resonance imaging (MRI) scanner to make scans affordable and accessible to everyone. Mobile MRI means the newest, most innovative technology in MRI delivered right to the doorstep in one complete package.

Global musculoskeletal diseases treatment market, based on the disease into arthritis, osteoarthritis, osteoporosis, spondylitis, and others. The arthritis is the largest segment among the disease segment in the musculoskeletal diseases treatment market in 2017 and is also anticipated to hold the largest market in the year 2025 owing to the increasing prevalence of the disease and the higher acceptance of the population for the MRI for the diagnosis. However, the spondylitis segment is fastest growing segment and is accounted to grow at the highest CAGR during the forecast period.

The imaging modality segment of the musculoskeletal diseases treatment market is segmented into magnetic resonance imaging (MRI), computed tomography (CT), ultrasound and others. The computed tomography (CT) is the largest segment among the imaging modality segment in the musculoskeletal diseases treatment market in 2017 and is also anticipated to hold the largest market in the year 2025. The ultrasound segment is fastest growing segment and is accounted to grow at the CAGR due to ultrasound images are captured in real-time, they can show the structure and movement of the body's internal organs, as well as blood flowing through blood vessels.

Some of the major primary and secondary sources included in the report for the Musculoskeletal Diseases Treatment market are World Health Organization (WHO), Canadian Centre for Occupational Health and Safety (CCOHS), National Cancer Institute, National Health Service, European Society of the Musculoskeletal Radiology, Center for Devices and Radiological Health, Food and Drug Administration, Public Health England, and Health Protection Agency among others.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the musculoskeletal diseases treatment market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global musculoskeletal diseases treatment market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Companies Mentioned

The List of Companies

  • 1. General Electric
  • 2. Koninklijke Philips N.V.
  • 3. Siemens AG
  • 4. Canon Medical Systems Corporation
  • 5. Hitachi, Ltd.
  • 6. Accuray Incorporated
  • 7. MR Solutions
  • 8. Alltech Medical Systems
  • 9. Terason Division Teratech Corporation
  • 10. Echo-Son SA

Table of Contents

1. INTRODUCTION

  • 1.1. SCOPE OF STUDY
  • 1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

2. KEY TAKEAWAYS

3. MUSCULOSKELETAL DISEASES TREATMENT MARKET LANDSCAPE

  • 3.1. MARKET OVERVIEW
  • 3.2. MARKET SEGMENTATION
    • 3.2.1. Musculoskeletal Diseases Treatment Market - By Type
    • 3.2.2. Musculoskeletal Diseases Treatment Market - By Imaging Modality
    • 3.2.3. Musculoskeletal Diseases Treatment Market - By Region
      • 3.2.3.1. By Country

4. MUSCULOSKELETAL DISEASES TREATMENT MARKET - KEY INDUSTRY DYNAMICS

  • 4.1. KEY MARKET DRIVERS
  • 4.2. KEY MARKET RESTRAINTS
  • 4.3. KEY MARKET OPPORTUNITIES
  • 4.4. FUTURE TRENDS
  • 4.5. IMPACT ANALYSIS

5. MUSCULOSKELETAL DISEASES TREATMENT MARKET - GLOBAL ANALYSIS

  • 5.1. GLOBAL MUSCULOSKELETAL DISEASES TREATMENT MARKET OVERVIEW
  • 5.2. GLOBAL MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
  • 5.3. PERFORMANCE OF KEY PLAYERS
  • 5.4. EXPERT OPINIONS

6. MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 - TYPE (US$ MN)

  • 6.1. OVERVIEW
  • 6.2. TYPE MARKET FORECASTS AND ANALYSIS
  • 6.3. ARTHRITIS MARKET
    • 6.3.1. Overview
    • 6.3.2. Arthritis Market Revenue Forecasts and Analysis (US$ Mn)
  • 6.4. OSTEOARTHRITIS MARKET
    • 6.4.1. Overview
    • 6.4.2. Osteoarthritis Market Revenue Forecasts and Analysis (US$ Mn)
  • 6.5. OSTEOPOROSIS MARKET
    • 6.5.1. Overview
    • 6.5.2. Osteoporosis Market Revenue Forecasts and Analysis (US$ Mn)
  • 6.6. SPONDYLITIS MARKET
    • 6.6.1. Overview
    • 6.6.2. Spondylitis Market Revenue Forecasts and Analysis (US$ Mn)
  • 6.7. OTHERS MARKET
    • 6.7.1. Overview
    • 6.7.2. Others Market Revenue Forecasts and Analysis (US$ Mn)

7. MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 -IMAGING MODALITY (US$ MN)

  • 7.1. OVERVIEW
  • 7.2. IMAGING MODALITY MARKET FORECASTS AND ANALYSIS
  • 7.3. MAGNETIC RESONANCE IMAGING (MRI) MARKET
    • 7.3.1. Overview
    • 7.3.2. Magnetic Resonance Imaging (MRI) Market Revenue Forecasts and Analysis (US$ Mn)
  • 7.4. COMPUTED TOMOGRAPHY (CT) MARKET
    • 7.4.1. Overview
    • 7.4.2. Computed Tomography (CT) Market Revenue Forecasts and Analysis (US$ Mn)
  • 7.5. ULTRASOUND MARKET
    • 7.5.1. Overview
    • 7.5.2. Ultrasound Market Revenue Forecasts and Analysis (US$ Mn)

8. NORTH AMERICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS

  • 8.1. NORTH AMERICA MUSCULOSKELETAL DISEASES TREATMENT MARKET OVERVIEW
  • 8.2. NORTH AMERICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
  • 8.3. NORTH AMERICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE FORECASTS AND ANALYSIS - BY TYPE (US$ MN)
  • 8.4. NORTH AMERICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE FORECASTS AND ANALYSIS - BY IMAGING MODALITY (US$ MN)
  • 8.5. NORTH AMERICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE FORECASTS AND ANALYSIS - BY COUNTRY
  • 8.6. US MARKET OVERVIEW
    • 8.6.1. US Musculoskeletal Diseases Treatment Market Revenue Forecasts and Analysis-By Type (US$ Mn)
    • 8.6.2. US Musculoskeletal Diseases Treatment Market Revenue Forecasts and Analysis-By Imaging Modality (US$ Mn)
  • 8.7. CANADA MARKET OVERVIEW
    • 8.7.1. Canada Musculoskeletal Diseases Treatment Market Revenue Forecasts and Analysis-By Type (US$ Mn)
    • 8.7.2. Canada Musculoskeletal Diseases Treatment Market Revenue Forecasts and Analysis- By Imaging Modality (US$ Mn)
  • 8.8. MEXICO MARKET OVERVIEW
    • 8.8.1. Mexico Musculoskeletal Diseases Treatment Market Revenue Forecasts and Analysis- By Type (US$ Mn)
    • 8.8.2. Mexico Musculoskeletal Diseases Treatment Market Revenue Forecasts and Analysis- By Imaging Modality (US$ Mn)

9. EUROPE MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS

  • 9.1. EUROPE MUSCULOSKELETAL DISEASES TREATMENT MARKET OVERVIEW
  • 9.2. EUROPE MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
  • 9.3. EUROPE MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE FORECASTS AND ANALYSIS - BY TYPE (US$ MN)
  • 9.4. EUROPE MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE FORECASTS AND ANALYSIS - BY IMAGING MODALITY (US$ MN)
  • 9.5. EUROPE MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE FORECASTS AND ANALYSIS - BY COUNTRY
  • 9.6. UK MARKET OVERVIEW
    • 9.6.1. UK Musculoskeletal Diseases Treatment Market Revenue Forecasts and Analysis- By Type (US$ Mn)
    • 9.6.2. UK Musculoskeletal Diseases Treatment Market Revenue Forecasts and Analysis- By Imaging Modality (US$ Mn)
  • 9.7. GERMANY MARKET OVERVIEW
    • 9.7.1. Germany Musculoskeletal Diseases Treatment Market Revenue Forecasts and Analysis- By Type (US$ Mn)
    • 9.7.2. Germany Musculoskeletal Diseases Treatment Market Revenue Forecasts and Analysis- By Imaging Modality (US$ Mn)
  • 9.8. FRANCE MARKET OVERVIEW
    • 9.8.1. France Musculoskeletal Diseases Treatment Market Revenue Forecasts and Analysis- By Type (US$ Mn)
    • 9.8.2. France Musculoskeletal Diseases Treatment Market Revenue Forecasts and Analysis- By Imaging Modality (US$ Mn)

10. ASIA PACIFIC MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS

  • 10.1. ASIA PACIFIC MUSCULOSKELETAL DISEASES TREATMENT MARKET OVERVIEW
  • 10.2. ASIA PACIFIC MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
  • 10.3. ASIA PACIFIC MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE FORECASTS AND ANALYSIS - BY TYPE (US$ MN)
  • 10.4. ASIA PACIFIC MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE FORECASTS AND ANALYSIS - BY IMAGING MODALITY (US$ MN)
  • 10.5. ASIA PACIFIC MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE FORECASTS AND ANALYSIS - BY COUNTRY
  • 10.6. JAPAN MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE OVERVIEW
    • 10.6.1. Japan Musculoskeletal Diseases Treatment Market Revenue Forecasts and Analysis- By Type (US$ Mn)
    • 10.6.2. Japan Musculoskeletal Diseases Treatment Market Revenue Forecasts and Analysis- By Imaging Modality (US$ Mn)
  • 10.7. CHINA MARKET OVERVIEW
    • 10.7.1. China Musculoskeletal Diseases Treatment Market Revenue Forecasts and Analysis- By Type (US$ Mn)
    • 10.7.2. China Musculoskeletal Diseases Treatment Market Revenue Forecasts and Analysis- By Imaging Modality (US$ Mn)
  • 10.8. INDIA MARKET OVERVIEW
    • 10.8.1. India Musculoskeletal Diseases Treatment Market Revenue Forecasts and Analysis- By Type (US$ Mn)
    • 10.8.2. India Musculoskeletal Diseases Treatment Market Revenue Forecasts and Analysis- By Imaging Modality (US$ Mn)

11. MIDDLE EAST & AFRICA (MEA) MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS

  • 11.1. MIDDLE EAST & AFRICA (MEA) MUSCULOSKELETAL DISEASES TREATMENT MARKET OVERVIEW
  • 11.2. MIDDLE EAST & AFRICA (MEA) MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
  • 11.3. MIDDLE EAST & AFRICA (MEA) MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE FORECASTS AND ANALYSIS - BY TYPE (US$ MN)
  • 11.4. MIDDLE EAST & AFRICA (MEA) MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE FORECASTS AND ANALYSIS - BY IMAGING MODALITY (US$ MN)
  • 11.5. MIDDLE EAST & AFRICA (MEA) MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE FORECASTS AND ANALYSIS - BY COUNTRY
  • 11.6. SOUTH AFRICA MARKET OVERVIEW
    • 11.6.1. South Africa Musculoskeletal Diseases Treatment Market Revenue Forecasts and Analysis- By Type (US$ Mn)
    • 11.6.2. South Africa Musculoskeletal Diseases Treatment Market Revenue Forecasts and Analysis- By Imaging Modality (US$ Mn)
  • 11.7. SAUDI ARABIA MARKET OVERVIEW
    • 11.7.1. Saudi Arabia Musculoskeletal Diseases Treatment Market Revenue Forecasts and Analysis- By Type (US$ Mn)
    • 11.7.2. Saudi Arabia Musculoskeletal Diseases Treatment Market Revenue Forecasts and Analysis- By Imaging Modality (US$ Mn)
  • 11.8. UAE MARKET OVERVIEW
    • 11.8.1. UAE Musculoskeletal Diseases Treatment Market Revenue Forecasts and Analysis- By Type (US$ Mn)
    • 11.8.2. UAE Musculoskeletal Diseases Treatment Market Revenue Forecasts and Analysis- By Imaging Modality (US$ Mn)

12. SOUTH AND CENTRAL AMERICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS

  • 12.1. SOUTH AND CENTRAL AMERICA MUSCULOSKELETAL DISEASES TREATMENT MARKET OVERVIEW
  • 12.2. SOUTH AND CENTRAL AMERICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
  • 12.3. SOUTH AND CENTRAL AMERICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE FORECASTS AND ANALYSIS - BY TYPE (US$ MN)
  • 12.4. SOUTH AND CENTRAL AMERICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE FORECASTS AND ANALYSIS - BY IMAGING MODALITY (US$ MN)
  • 12.5. SOUTH AND CENTRAL AMERICA MUSCULOSKELETAL DISEASES TREATMENT MARKET REVENUE FORECASTS AND ANALYSIS - BY COUNTRY
  • 12.6. BRAZIL MARKET OVERVIEW
    • 12.6.1. Brazil Musculoskeletal Diseases Treatment Market Revenue Forecasts and Analysis-By Type (US$ Mn)
    • 12.6.2. Brazil Musculoskeletal Diseases Treatment Market Revenue Forecasts and Analysis-By Imaging Modality (US$ Mn)

13. INDUSTRY LANDSCAPE

  • 13.1. ORGANIC GROWTH STRATEGIES
    • 13.1.1. New Type Launches
    • 13.1.2. Marketing & Promotional Activities
  • 13.2. INORGANIC GROWTH STRATEGIES
    • 13.2.1. Partnerships, Collaborations, and Joint Ventures
    • 13.2.2. Mergers & Acquisitions

14. MUSCULOSKELETAL DISEASES TREATMENT MARKET, KEY COMPANY PROFILES

  • 14.1. CANON MEDICAL SYSTEMS
    • 14.1.1. Key Facts
    • 14.1.2. Business Description
    • 14.1.3. Financial Overview
    • 14.1.4. Product Portfolio
    • 14.1.5. SWOT Analysis
    • 14.1.6. Key Developments
  • 14.2. SIEMENS AG
    • 14.2.1. Key Facts
    • 14.2.2. Business Description
    • 14.2.3. Financial Overview
    • 14.2.4. Product Portfolio
    • 14.2.5. SWOT Analysis
    • 14.2.6. Key Developments
  • 14.3. ESAOTE S.P.A
    • 14.3.1. Key Facts
    • 14.3.2. Business Description
    • 14.3.3. Financial Overview
    • 14.3.4. Product Portfolio
    • 14.3.5. SWOT Analysis
    • 14.3.6. Key Developments
  • 14.4. HITACHI
    • 14.4.1. Key Facts
    • 14.4.2. Business Description
    • 14.4.3. Financial Overview
    • 14.4.4. Product Portfolio
    • 14.4.5. SWOT Analysis
    • 14.4.6. Key Developments
  • 14.5. KONINKLIJKE PHILIPS N.V.
    • 14.5.1. Key Facts
    • 14.5.2. Business Description
    • 14.5.3. Financial Overview
    • 14.5.4. Product Portfolio
    • 14.5.5. SWOT Analysis
    • 14.5.6. Key Developments
  • 14.6. GENERAL ELECTRIC
    • 14.6.1. Key Facts
    • 14.6.2. Business Description
    • 14.6.3. Financial Overview
    • 14.6.4. Product Portfolio
    • 14.6.5. SWOT Analysis
    • 14.6.6. Key Developments
  • 14.7. SHIMADZU CORPORATION
    • 14.7.1. Key Facts
    • 14.7.2. Business Description
    • 14.7.3. Financial Overview
    • 14.7.4. Product Portfolio
    • 14.7.5. SWOT Analysis
    • 14.7.6. Key Developments
  • 14.8. FUJIFILM HOLDINGS CORPORATION
    • 14.8.1. Key Facts
    • 14.8.2. Business Description
    • 14.8.3. Financial Overview
    • 14.8.4. Product Portfolio
    • 14.8.5. SWOT Analysis
    • 14.8.6. Key Developments
  • 14.9. ACCURAY INCORPORATED
    • 14.9.1. Key Facts
    • 14.9.2. Business Description
    • 14.9.3. Financial Overview
    • 14.9.4. Product Portfolio
    • 14.9.5. SWOT Analysis
    • 14.9.6. Key Developments
  • 14.10. TOSHIBA CORPORATION
    • 14.10.1. Key Facts
    • 14.10.2. Business Description
    • 14.10.3. Financial Overview
    • 14.10.4. Product Portfolio
    • 14.10.5. SWOT Analysis
    • 14.10.6. Key Developments

15. APPENDIX

  • 15.1. ABOUT THE INSIGHT PARTNERS
  • 15.2. GLOSSARY OF TERMS
  • 15.3. RESEARCH METHODOLOGY
Back to Top